Peripheral neuropathy and neurosteroid formation in the central nervous system

Brain Research Reviews

Volumn 57, Issue 2, 2008, Pages 454-459

  Patte Mensah, Christine ^a   Mensah Nyagan, Ayikoe Guy ^a  

^a CNRS   (France)

Author keywords

Brainstem; Cytochrome P450scc; Neuroactive steroid; Neuroprotection; Neurosteroid; Nociception; Pain; Spinal cord

Indexed keywords

CHOLESTEROL MONOOXYGENASE (SIDE CHAIN CLEAVING); NEUROSTEROID; PRASTERONE; PREGNENOLONE; PROGESTERONE;

AUTOCRINE EFFECT; BIOLOGICAL ACTIVITY; GENE EXPRESSION; IMMUNOCYTOCHEMISTRY; NEUROPROTECTION; NOCICEPTION; NONHUMAN; PAIN; PARACRINE SIGNALING; PERIPHERAL NERVE INJURY; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REVIEW; SPINAL CORD; STEROIDOGENESIS;

ANIMALS; CENTRAL NERVOUS SYSTEM; GENE EXPRESSION; HUMANS; NEURONS; PERIPHERAL NERVOUS SYSTEM DISEASES; STEROIDS;

EID: 40849118468     PISSN: 01650173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainresrev.2007.05.007     Document Type: Review

References (56)

1. Attal N., Jazat F., Kayser V., and Guilbaud G. Further evidence for 'pain-related' behaviours in a model of unilateral peripheral mononeuropathy. Pain 41 (1990) 235-251
2. Baulieu E.E., Robel P., and Schumacher M. Contemporar y Endocrinology (1999), Hu mana Press, Totowa
3. Belelli D., and Lambert J.J. Neurosteroids: endogenous regulators of the GABA(A) receptor. Nat. Rev., Neurosci. 6 (2005) 565-575
4. Bennett G.J., and Xie Y.K. A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man. Pain 33 (1988) 87-107
5. Brinton R.D., and Wang J.M. Preclinical analyses of the therapeutic potential of allopregnanolone to promote neurogenesis in vitro and in vivo intransgenic mouse model of Alzheimer's disease. Curr. Alzheimer Res. 3 (2006) 11-17
6. Brinton R.D., and Wang J.M. Therapeutic potential of neurogenesis for prevention and recovery from Alzheimer's disease: allopregnanolone as a proof of concept neurogenic agent. Curr. Alzheimer Res. 3 (2006) 185-190
7. Compagnone N.A., and Mellon S.H. Neurosteroids: biosynthesis and function of these novel neuromodulators. Front. Neuroendocrinol. 21 (2000) 1-56
8. Dawson-Basoa M., and Gintzler A.R. Involvement of spinal cord delta opiate receptors in the antinociception of gestation and its hormonal simulation. Brain Res. 757 (1997) 37-42
9. Dawson-Basoa M., and Gintzler A.R. Gestational and ovarian sex steroid antinociception: synergy between spinal kappa and delta opioid systems. Brain Res. 794 (1998) 61-67
10. Dyck P.J., Karnes J., O'Brien P., Nukada H., Lais A., and Low P. Spatial pattern of nerve fiber abnormality indicative of pathologic mechanism. Am. J. Pathol. 117 (1984) 225-238
11. Frye C.A., and Vongher J.M. Progesterone and 3alpha,5alpha-THP enhance sexual receptivity in mice. Behav. Neurosci. 115 (2001) 1118-1128
12. Frye C.A., Duncan J.E., Basham M., and Erskine M.S. Behavioral effects of 3 alpha-androstanediol: II. Hypothalamic and preoptic, area actions via a GABAergic mechanism. Behav. Brain Res. 79 (1996) 119-130
13. Frye C.A., Rhodes M.E., Rosellini R., and Svare B. The nucleus accumbens as a site of action for rewarding properties of testosterone and its 5alpha-reduced metabolites. Pharmacol. Biochem. Behav. 74 (2002) 119-127
14. Garcia-Segura L.M., Azcoitia I., and DonCarlos L.L. Neuroprotection by estradiol. Prog. Neurobiol. 63 (2001) 29-60
15. Garcia-Segura L.M., Veiga S., Sierra A., Melcangi R.C., and Azcoitia I. Aromatase: a neuroprotective enzyme. Prog. Neurobiol. 71 (2003) 31-41
16. Gonzalez Deniselle M.C., Lopez-Costa J.J., Saavedra J.P., Pietranera L., Gonzalez S.L., Garay L., Guennoun R., Schumacher M., and De Nicola A.F. Progesterone neuroprotection in the Wobbler mouse, a genetic model of spinal cord motor neuron disease. Neurobiol. Dis. 11 (2002) 457-468
17. Goodchild C.S., Guo Z., and Nadeson R. Antinociceptive properties of neurosteroids: I. Spinally-mediated antinociceptive effects of water-soluble aminosteroids. Pain 88 (2000) 23-29
18. Goodchild C.S., Robinson A., and Nadeson R. Antinociceptive properties of neurosteroids: IV. Pilot study demonstrating the analgesic effects of alphadolone administered orally to humans. Br. J. Anaesth. 86 (2001) 528-534
19. Griffin L.D., Gong W., Verot L., and Mellon S.H. Niemann-Pick type C disease involves disrupted neurosteroidogenesis and responds to allopregnanolone. Nat. Med. 10 (2004) 704-711
20. Guennoun R., Schumacher M., Robert F., Delespierre B., Gouezou M., Eychenne B., Akwa Y., Robel P., and Baulieu E.E. Neuro steroids: expression of functional 3 beta-hydroxysteroid dehydrogenase by rat sensory neurons and Schwann cells. Eur. J. Neurosci. 9 (1997) 2236-2247
21. Higashi T., Nagahama A., Otomi N., and Shimada K. Studies on neurosteroids: XIX. Development and validation of liquid chromatography-tandem mass spectrometric method for determination of 5alpha-reduced pregnane-type neurosteroids in rat brain and serum. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 848 (2007) 188-199
22. Joseph E.K., and Levine J.D. Caspase signalling in neuropathic and inflammatory pain in the rat. Eur. J. Neurosci. 20 (2004) 2896-2902
23. Kibaly C., Patte-Mensah C., and Mensah-Nyagan A.G. Molecular and neurochemical evidence for the biosynthesis of dehydroepiandrosterone in the adult rat spinal cord. J. Neurochem. 93 (2005) 1220-1230
24. Kohno T., Ji R.R., Ito N., Allchorne A.J., Befort K., Karchewski L.A., and Woolf C.J. Peripheral axonal injury results in reduced mu opioid receptor pre- and post-synaptic action in the spinal cord. Pain 117 (2005) 77-87
25. Le Goascogne C., Robel P., Gouezou M., Sananes N., Baulieu E.E., and Waterman M. Neurosteroids: cytochrome P-450scc in rat brain. Science 237 (1987) 1212-1215
26. Leonelli E., Bianchi R., Cavaletti G., Caruso D., Crippa D., Garcia-Segura L.M., Lauria G., Magnaghi V., Roglio I., and Melcangi R.C. Progesterone and its derivatives are neuroprotective agents in experimental diabetic neuropathy: a multimodal analysis. Neuroscience 144 (2007) 1293-1304
27. Maione S., Siniscalco D., Galderisi U., de Novellis V., Uliano R., Di Bernardo G., Berrino L., Cascino A., and Rossi F. Apoptotic genes expression in the lumbar dorsal horn in a model neuropathic pain in rat. NeuroReport 13 (2002) 101-106
28. Mellon S.H., and Griffin L.D. Neurosteroids: biochemistry and clinical significance. Trends Endocrinol. Metab. 13 (2002) 35-43
29. Mensah-Nyagan A.G., Feuilloley M., Dupont E., Do-Rego J.L., Leboulenger F., Pelletier G., and Vaudry H. Immunocytochemical localization and biological activity of 3 beta-hydroxysteroid dehydrogenase in the central nervous system of the frog. J. Neurosci. 14 (1994) 7306-7318
30. Mensah-Nyagan A.G., Do-Rego J.L., Feuilloley M., Marcual A., Lange C., Pelletier G., and Vaudry H. In vivo and in vitro evidence for the biosynthesis of testosterone in the telencephalon of the female frog. J. Neurochem. 67 (1996) 413-422
31. Mensah-Nyagan A.G., Feuilloley M., Do-Rego J.L., Marcual A., Lange C., Tonon M.C., Pelletier G., and Vaudry H. Localization of 17beta-hydroxysteroid dehydrogenase and characterization of testosterone in the brain of the male frog. Proc. Natl. Acad. Sci. U. S. A. 93 (1996) 1423-1428
32. Mensah-Nyagan A.G., Do-Rego J.L., Beaujean D., Luu-The V., Pelletier G., and Vaudry H. Neurosteroids: expression of steroidogenic enzymes and regulation of steroid biosynthesis in the central nervous system. Pharmacol. Rev. 51 (1999) 63-81
33. Millan M.J. Th e induction of pain: an integrative review. Prog. Neurobiol. 57 (1999) 1-164
34. Millan M.J. Descending control of pain. Prog. Neurobiol. 66 (2002) 355-474
35. Moore K.A., Kohno T., Karchewski L.A., Scholz J., Baba H., and Woolf C.J. Partial peripheral nerve injury promotes a selective loss of GABAergic inhibition in the superficial dorsal horn of the spinal cord. J. Neurosci. 22 (2002) 6724-6731
36. Murakami K., Fellous A., Baulieu E.E., and Robel P. Pregnenolone binds to microtubule-associated protein 2 and stimulates microtubule assembly. Proc. Natl. Acad. Sci. U. S. A. 97 (2000) 3579-3584
37. Nadeson R., and Goodchild C.S. Antinociceptive properties of neurosteroids: I. Spinally-mediated antinociceptive effects of water-soluble aminosteroids. Pain 88 (2000) 23-29
38. A receptors. Pain 88 (2000) 31-39
39. Nadeson R., and Goodchild C.S. Antinociceptive properties of neurosteroids: III. Experiments with alphadolone given intravenously, intraperitoneally and intragastrically. Br. J. Anaesth. 86 (2001) 704-708
40. Panzica G.C., Aste N., Castagna C., Viglietti-Panzica C., and Balthazart J. Steroid-induced plasticity in the sexually dimorphic vasotocinergic innervation of the avian brain: behavioral implications. Brain Res. Brain Res. Rev. 37 (2001) 178-200
41. Patte-Mensah C., Kappes V., Freund-Mercier M.J., Tsutsui K., and Mensah-Nyagan A.G. Cellular distribution and bioactivity of the key steroidogenic enzyme, cytochrome P450side chain cleavage, in sensory neural pathways. J. Neurochem. 86 (2003) 1233-1246
42. Patte-Mensah C., Li S., and Mensah-Nyagan A.G. Impact of neuropathic pain on the gene expression and activity of cytochrome P450side-chain-cleavage in sensory neural networks. Cell. Mol. Life Sci. 61 (2004) 2274-2284
43. Patte-Mensah C., Kibaly C., Boudard D., Schaeffer V., Begle A., Saredi S., Meyer L., and Mensah-Nyagan A.G. Neurogenic pain and steroid synthesis in the spinal cord. J. Mol. Neurosci. 28 (2006) 17-31
44. Plassart-Schiess E., and Baulieu E.E. Neurosteroids: recent findings. Brain Res. Brain Res. Rev. 37 (2001) 133-140
45. Saredi S., Patte-Mensah C., Melcangi R.C., and Mensah-Nyagan A.G. Effect of streptozotocin-induced diabetes on the gene expression and biological activity of 3beta-hydroxysteroid dehydrogenase in the rat spinal cord. Neuroscience 135 (2005) 869-877
46. Schumacher M., Weill-Engerer S., Liere P., Robert F., Franklin R.J., Garcia-Segura L.M., Lambert J.J., Mayo W., Melcangi R.C., Parducz A., Suter U., Carelli C., Baulieu E.E., and Akwa Y. Steroid hormones and neurosteroids in normal and pathological aging of the nervous system. Prog. Neurobiol. 71 (2003) 3-29
47. Schumacher M., Guennoun R., Robert F., Carelli C., Gago N., Ghoumari A., Gonzalez Deniselle M.C., Gonzalez S.L., Ibanez C., Labombarda F., Coirini H., Baulieu E.E., and De Nicola A.F. Local synthesis and dual actions of progesterone in the nervous system: neuroprotection and myelination. Growth Horm. IGF Res. 14 Suppl. A (2004) S18-S33
48. Stoffel-Wagner B. Neurosteroid metabolism in the human brain. Eur. J. Endocrinol. 145 (2001) 669-679
49. Thomas A.J., Nockels R.P., Pan H.Q., Shaffrey C.I., and Chopp M. Progesterone is neuroprotective after acute experimental spinal cord trauma in rats. Spine 24 (1999) 2134-2138
50. Ueda H., Inoue M., Yoshida A., Mizuno K., Yamamoto H., Maruo J., Matsuno K., and Mita S. Metabotropic neurosteroid/sigma-receptor involved in stimulation of nociceptor endings of mice. J. Pharmacol. Exp. Ther. 298 (2001) 703-710
51. Uzunova V., Sheline Y., Davis J.M., Rasmusson A., Uzunov D.P., Costa E., and Guidotti A. Increase in the cerebrospinal fluid content of neurosteroids in patients with unipolar major depression who are receiving fluoxetine or fluvoxamine. Proc. Natl. Acad. Sci. U. S. A. 95 (1998) 3239-3244
52. Wang L.X., and Wang Z.J. Animal and cellular models of chronic pain. Adv. Drug Delivery Rev. 55 (2003) 949-965
53. Wang J.M., Johnston P.B., Ball B.G., and Brinton R.D. The neurosteroid allopregnanolone promotes proliferation of rodent and human neural progenitor cells and regulates cell-cycle gene and protein expression. J. Neurosci. 25 (2005) 4706-4718
54. Weill-Engerer S., David J.P., Sazdovitch V., Liere P., Eychenne B., Pianos A., Schumacher M., Delacourte A., Baulieu E.E., and Akwa Y. Neurosteroid quantification in human brain regions: comparison between Alzheimer's and nondemented patients. J. Clin. Endocrinol. Metab. 87 (2002) 5138-5143
55. Whiteside G.T., and Munglani R. Cell death in the superficial dorsal horn in a model of neuropathic pain. J. Neurosci. Res. 64 (2001) 168-173
56. Woolf C.J., and Salter M.W. Neuronal plasticity: increasing the gain in pain. Science 288 (2000) 1765-1769